Description
Dasatinib, marketed under the brand name SPRYCEL, It is an prescription medication that has been approved by the FDA on multiple dates for different indications:
June 28, 2006: Accelerated approval for adults with chronic myeloid leukemia (CML), accelerated CML, or myeloid or lymphoid blast phase CML. Dasatinib was also approved for adults with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
October 28, 2010: Approval for 80 mg and 140 mg strengths of dasatinib.
November 9, 2017: Approval for children with Ph+ CML in the chronic phase.
What is SPRYCEL (dasatinib) ?
SPRYCEL® (dasatinib) is indicated for the treatment of adults with: Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. Chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia
How to order approved “SPRYCEL (dasatinib) for tablets” Medicine?
SPRYCEL (Dasatinib) Tablet is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing SPRYCEL and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.